Axsome Therapeutics (AXSM) EPS (Basic) (2015 - 2026)
Axsome Therapeutics (AXSM) reported EPS (Basic) of -$1.26 for Q1 2026, down 3.69% on a YoY basis from -$1.31 in Q1 2025, and down 119.04% sequentially from -$0.58 in Q4 2025.
Axsome Therapeutics (AXSM) EPS (Basic) (2015 - 2026) Analysis & Trends
Axsome Therapeutics (AXSM) has 12 years of EPS (Basic) data on file, last reported at -$1.26 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 3.69% year-over-year to -$1.26; the trailing twelve-month figure through Mar 2026 stood at -$3.68 (up 35.38% YoY), and the FY2025 full-year result was -$3.68, up 38.56% from the prior year.
- EPS (Basic) slipped to -$1.26 in Q1 2026, from -$0.58 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.26 in Q1 2023 to a low of -$2.17 in Q4 2023.
- A 5-year average of -$1.23 and a median of -$1.26 in 2026 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) soared 81.76% in 2022 and tumbled 458.6% in 2024, its largest moves.
- Tracing AXSM's EPS (Basic) over 5 years: stood at -$1.51 in 2022, then slumped by 44.15% to -$2.17 in 2023, then climbed by 28.0% to -$1.56 in 2024, then jumped by 63.19% to -$0.58 in 2025, then sank by 119.04% to -$1.26 in 2026.
- Business Quant data shows AXSM's EPS (Basic) at -$1.26 in Q1 2026, -$0.58 in Q4 2025, and -$0.94 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Axsome Therapeutics | 12.37 Bn | 12.06 Bn | 176.48 Mn | -1.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.26 |
| Dec 31, 2025 | -0.58 |
| Sep 30, 2025 | -0.94 |
| Jun 30, 2025 | -0.97 |
| Mar 31, 2025 | -1.22 |
| Dec 31, 2024 | -1.56 |
| Sep 30, 2024 | -1.34 |
| Jun 30, 2024 | -1.67 |
| Mar 31, 2024 | -1.44 |
| Dec 31, 2023 | -2.17 |
| Sep 30, 2023 | -1.32 |
| Jun 30, 2023 | -1.54 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | -1.51 |
| Sep 30, 2022 | -1.07 |
| Jun 30, 2022 | -1.06 |
| Mar 31, 2022 | -1.03 |
| Dec 31, 2021 | -0.93 |
| Sep 30, 2021 | -5.82 |
| Jun 30, 2021 | -5.81 |